Aries Wealth Management Seres Therapeutics, Inc. Transaction History

Aries Wealth Management

  • $361 Million
  • Q1 2025

A detailed history of Aries Wealth Management transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Aries Wealth Management holds 15,000 shares of MCRB stock, worth $217,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,000
Previous 15,000 -0.0%
Holding current value
$217,950
Previous $12,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
SELL
$0.7 - $1.48 $1,400 - $2,960
-2,000 Reduced 11.76%
15,000 $14,000
Q2 2024

Jul 25, 2024
BUY
$0.56 - $1.19 $2,800 - $5,950
5,000 Added 41.67%
17,000 $12,000
Q4 2023

Jan 10, 2024
SELL
$0.93 - $2.15 $5,580 - $12,900
-6,000 Reduced 33.33%
12,000 $16,000
Q2 2023

Jul 13, 2023
BUY
$4.67 - $6.55 $28,020 - $39,300
6,000 Added 50.0%
18,000 $86,000
Q1 2023

Apr 11, 2023
BUY
$4.95 - $6.09 $9,900 - $12,180
2,000 Added 20.0%
12,000 $68,000
Q3 2022

Nov 02, 2022
BUY
$3.5 - $7.2 $35,000 - $72,000
10,000 New
10,000 $89,000
Q4 2021

Jan 18, 2022
BUY
$6.02 - $11.43 $210,699 - $400,050
35,000 New
35,000 $292,000
Q3 2020

Oct 14, 2020
SELL
$3.74 - $28.74 $37,400 - $287,400
-10,000 Closed
0 $0
Q3 2019

Oct 22, 2019
BUY
$2.29 - $4.16 $22,900 - $41,600
10,000 New
10,000 $31,000

Others Institutions Holding MCRB

# of Institutions
59
Shares Held
38.3M
Call Options Held
103K
Put Options Held
53K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $1.8B
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Aries Wealth Management Portfolio

Follow Aries Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aries Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Aries Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email